PMN
ProMIS Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$12.60
−2.33%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-85.5%
Return on equity
-74.5%
Return on assets
-87.9%
Return on invested capital
0.00x
Asset turnover
-$42.0M
Cash from operations
$5.96
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026